2,4,6-Triaminopyrimidines for the treatment of depression and/or anxiety
AssigneeH. Lunobeck A/S
InventorMathivanan Packiarajan
Life of this patent
Estimating the term…
Loading patent…
AssigneeH. Lunobeck A/S
InventorMathivanan Packiarajan
Estimating the term…
This invention is directed to pyrimidine derivatives which are selective antagonists for the GalR3 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety. This invention also provides a method of treating depression and/or anxiety in a subject which comprises administering to the subject a composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a GalR3 receptor antagonist.
A compound having the structure:
A compound having the structure:
A compound having the structure:
A compound having the structure:
A compound having the structure:
A compound having the structure:
Dependencies are inferred from the claim text.